APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,280 | +22.0% | 3,898 | +192.2% | 0.00% | – |
| Q2 2023 | $121,528 | +40.5% | 1,334 | +1.8% | 0.00% | – |
| Q1 2023 | $86,473 | +134.2% | 1,311 | +83.6% | 0.00% | – |
| Q4 2022 | $36,921 | -87.3% | 714 | -83.3% | 0.00% | -100.0% |
| Q3 2022 | $291,000 | +1611.8% | 4,267 | +1069.0% | 0.00% | – |
| Q2 2022 | $17,000 | -69.6% | 365 | -67.1% | 0.00% | – |
| Q1 2022 | $56,000 | +409.1% | 1,110 | +391.2% | 0.00% | – |
| Q4 2021 | $11,000 | -8.3% | 226 | -34.1% | 0.00% | – |
| Q3 2021 | $12,000 | +33.3% | 343 | +145.0% | 0.00% | – |
| Q2 2021 | $9,000 | +125.0% | 140 | +30.8% | 0.00% | – |
| Q1 2021 | $4,000 | -33.3% | 107 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 107 | +256.7% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 30 | -58.9% | 0.00% | – |
| Q2 2020 | $2,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |